BDLIB
VRTX icon

Banque de Luxembourg Investments (BLI)’s Vertex Pharmaceuticals VRTX Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Hold
5,500
– – 0.07% 148
2025
Q4 		$2.5M Sell
5,500
-700
-11% -$302K 0.07% 151
2025
Q3 		$2.45M Sell
6,200
-300
-5% -$125K 0.07% 144
2025
Q2 		$2.87M Buy
+6,500
New +$3M 0.08% 149

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s VRTX Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 5,500 shares worth $2.46M. The position accounts for 0.07% of the portfolio, ranked #148.

Banque de Luxembourg Investments (BLI) first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.87M in Q2 2025. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 5,500 shares of Vertex Pharmaceuticals worth $2.46M as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.07% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #148 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Vertex Pharmaceuticals position peaked at $2.87M in Q2 2025.
  • 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.